Sort by
Refine Your Search
-
Postdoc Computational science for energy materials (X/F/M) Postdoc Computational science for energy materials (X/F/M) Published Deadline Location today 5 May Eindhoven Have you recently completed a
-
Career Programme for partners and they organise events to expand your (social) network. Employer Delft University of Technology Delft University of Technology is built on strong foundations. As creators
-
Postdoc Automated Reasoning in Quantum Computing (0.8-1.0 FTE) Postdoc Automated Reasoning in Quantum Computing (0.8-1.0 FTE) Published Deadline Location today 30 Apr Leiden The Faculty of Science
-
Service offers a Dual Career Programme for partners and they organise events to expand your (social) network. Employer Delft University of Technology Delft University of Technology is built on strong
-
biology. Knowledge and hand-on experience in Computer Aided Design, MATLAB, bioinformatics, and biomarkers is highly appreciated. We expect to have excellent communication skills and a collaborative mindset
-
, Computational Linguistics, Information Retrieval or Data Science with an interest in Humanities research. The position is vacated on Postdoc level. We thus invite applications of candidates with a PhD to apply
-
connection with: Biology, Chemistry, Information and Computing Sciences, Mathematics, Pharmaceutical Sciences and Physics. Each of these is made up of distinct institutes that work together to focus
-
. The overarching aim of RIMLS-Science is to decipher molecular mechanisms of disease. Research areas of RIMLS-Science include epigenetics, stem-cell and developmental biology, and computational biology. The central
-
career program. Candidates from outside the Netherlands may be eligible for a substantial tax break. Diversity At the Faculty of Science, we value inclusiveness and strive for a diverse community with
-
Post-doc in Molecular Cartilage Biology and discovery of osteoarthritis disease-modifying drugs Post-doc in Molecular Cartilage Biology and discovery of osteoarthritis disease-modifying drugs